Furthermore, GM-CSF secretion by tumor cells has been shown to boost anti-tumor immunity, and a number of human clinical studies are using recombinant GM-CSF injections into the tumor, GM-CSF fused with tumor-associated proteins in cancer vaccines, and anti-cancer DNA vaccines incorporating GM-CSF [31]. This evidence concerns the gene CSF2 and cancer.